Tusk Venture Partners is a New York City-based early-stage venture capital firm that invests in technology companies operating in highly regulated markets. It was the first VC fund to focus solely on startups navigating regulatory and political barriers.
32% of their portfolio is in Healthcare. Average disclosed round size is $36.7M (across 58 rounds with reported amounts).
Portfolio
49
Fund Size
$140M
Top Stage
Seed
Last 12 Mo
5
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
62 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Hint | Seed | $10M | May 2026 |
 Somethings | Series A | $19.2M | Feb 2026 |
| Hint | Seed | $10M | Jan 2026 |
 Flex | Series B | $60M | Dec 2025 |
| FFlexbase Technologies, Inc. | Series B | $60M | Dec 2025 |
 Flex | Series B | $60M | Dec 2025 |
 Doctronic | Series A | $20M | Sep 2025 |
 Hyper | Seed | $6.3M | Jul 2025 |
 Lumion | Seed | $10.7M | Jun 2025 |
 Lumion | Seed | $10.7M | Jun 2025 |
 Lumion | Unknown | $10.7M | Jun 2025 |
 Odyssey | Series A | $10M | May 2024 |
 dub | Seed | $17M | Feb 2024 |
 Dub | Seed | $17M | Jan 2024 |
| dub | Series A | $30M | Jan 2024 |
 Kodex | Seed | $10M | Nov 2023 |
 Kodex | Seed | $10M | Nov 2023 |
| KKodex | Seed | $10M | Nov 2023 |
 TBD Health | Seed | $4.4M | Jan 2023 |
 TBD Health | Seed | $4.4M | Jan 2023 |
 Elaborate | Seed | $10M | Jan 2023 |
 Rx Redefined | Series A | $8M | Jan 2023 |
 Magna | Seed | $15M | Sep 2022 |
 Alma | Unknown | $130M | Aug 2022 |
| HHelloalma Com | Series D | $130M | Aug 2022 |
Page 1 of 3
Top Co-Investors
Nexus Venture Partners10 shared
Tusk Ventures9 shared
Sound Ventures8 shared
Insight Partners8 shared
Index Ventures7 shared
Rainfall Ventures7 shared
Primary Venture Partners7 shared
Optum Ventures7 shared
Sequoia Capital5 shared
Lightspeed Venture Partners5 shared
Thoma Bravo5 shared
The Cigna Group Ventures5 shared
CRV4 shared
Valor Equity Partners4 shared
General Catalyst4 shared
Slow Ventures4 shared
Y Combinator4 shared
Craft Ventures3 shared
Greycroft3 shared
Goldcrest Capital3 shared
Last updated: 20 October 2026